Company Performance Metrics
Pranav Sharma: Founder & Chief Scientific Officer
Problem: About 20% of the population in the United States suffers from a diagnosable mental illness. Brain disorder therapeutics is a ~$100B market with just 50% patient reach and poised to grow at a rapid rate. Despite huge market and unmet need, the drugs targeting brain disorders range from ineffective to partially effective and treat symptoms
rather than altering the course of disease. Solution: Exosomes are transportation and logistics services of the body that carry biomolecules to specific cellular targets and have capability to heal the defective cells and tissues. We harness the targeting capability of exosomes to improve the efficacy of current drugs and healing capability of exosomes to usher a new era of therapeutics for the brain disorders.
